Next Article in Journal
Monocytes and Macrophages Serve as Potent Prostaglandin D2 Sources during Acute, Non-Allergic Pulmonary Inflammation
Next Article in Special Issue
Hypothalamic Regulation of Corticotropin-Releasing Factor under Stress and Stress Resilience
Previous Article in Journal
Pharmacogenetics of Drug-Resistant Epilepsy (Review of Literature)
Previous Article in Special Issue
Biphasic Roles of Clock Genes and Bone Morphogenetic Proteins in Gonadotropin Expression by Mouse Gonadotrope Cells
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Involvement of Ghrelin Dynamics in Stress-Induced Eating Disorder: Effects of Sex and Aging

Tsumura Kampo Research Laboratories, Tsumura & Co., Ibaraki 300-1192, Japan
Int. J. Mol. Sci. 2021, 22(21), 11695; https://doi.org/10.3390/ijms222111695
Submission received: 30 August 2021 / Revised: 25 October 2021 / Accepted: 27 October 2021 / Published: 28 October 2021
(This article belongs to the Special Issue Molecular Mechanisms Underlying Stress Response and Resilience)

Abstract

:
Stress, a factor that affects appetite in our daily lives, enhances or suppresses appetite and changes palatability. However, so far, the mechanisms underlying the link between stress and eating have not been fully elucidated. Among the peripherally produced appetite-related peptides, ghrelin is the only orexigenic peptide, and abnormalities in the dynamics and reactivity of this peptide are involved in appetite abnormalities in various diseases and psychological states. This review presents an overview of the research results of studies evaluating the effects of various stresses on appetite. The first half of this review describes the relationship between appetite and stress, and the second half describes the relationship between the appetite-promoting peptide ghrelin and stress. The effects of sex differences and aging under stress on appetite are also described.

1. Overview of Stress and Feeding

Stress may be defined as the physiological process of what is perceived to be harmful to an individual. We routinely experience various types of mild to severe stress. For example, emotional impacts resulting from environmental changes and sad experiences, such as the death of a family member or a close acquaintance, and intense painful physiological impacts, such as dietary restrictions and injuries, are also defined as stress. Stress can affect biological functions, depending on its type, severity, and duration. Stressors commonly experienced in daily life affect appetite [1,2], gastrointestinal motility [3,4], and digestive function [5]. Furthermore, the physiological response may differ depending on whether the events are acute or chronic. Acute stress is considered an adaptive mechanism of the body, but chronic stress can damage various biological functions. Notably, several factors paradoxically influence the appetitive response to stressors. Mild but acute stress and intense stress, for instance, enhance the release of adrenaline and glucocorticoids [6] and reduce appetite. The persistence of this condition affects energy balance and can result in nutritional problems. Furthermore, constant exposure to stressors in daily life increases appetite and potentially causes bulimia [7,8]. Chronic stress affects gastrointestinal functions, such as motility [9], and brain functions, such as cognition, memory, and learning [10,11]. Chronic stress can affect food preferences and promote the craving and intake of palatable high-fat and energy-dense foods [12,13]. Under chronic stress, the glucose and salt susceptibility threshold is lowered and sugar intake is increased [14]. An important area of the brain activated by stress is the ventral tegmental area (VTA), or nucleus accumbens, and chronically given stressors act on the reward system to increase appetite or change the taste of food. Thus, the basic or clinical outcomes suggesting that stress increases appetite, alters palatability, and causes weight gain are beginning to increase. However, so far, the clinical evaluation of stress-reducing appetite remains limited and the elucidation of the underlying mechanism using animals has not progressed much.
Clinical trials in which participants are stressed to reduce their food intake are ethically problematic and require ingenuity. Additionally, few clinical indicators objectively evaluate appetite. The amount of consumed food, calorie intake, three-factor eating questionnaire [15], Satter eating competence inventory [16], and perceived stress scale [17] are used to measure appetite. However, under stress, there remains a debate whether the application of the former two is appropriate. In basic research, it is common to measure the amount of food consumed during a fixed time [18]. Moreover, the time to approach food (i.e., latency to eat), such as graham cracker crumbs, and the amount of food eaten first (i.e., first meal amount) may be evaluated as motivation for eating [19,20]. The feeding behavior of mice has recently been automatically measured, and meal patterns, such as the number of bouts, their intervals, and meal size have been evaluated [21,22]. In addition to glucocorticoid levels in the blood, food intake has become the most associated event that occurs under stress. Anorexia and bulimia are believed to be caused by multiple known and unknown biological factors. So far, the advancements in brain analysis through neuroimaging have revealed some dysfunctions common to each symptom [23]. Furthermore, endocrinological approaches have been used to elucidate the potential role of dysfunction in several neuropsychiatric and appetite-related peptides. Such approaches are an important tool for determining the detailed mechanisms of anorexia and overeating. However, the detailed mechanism of an eating abnormality during stress has not been elucidated in depth.
This review focuses on the suppressive effect of stress on appetite: (1) Typical intrinsic factors that control appetite and stress; (2) ghrelin dysfunction; (3) the relationship between ghrelin reactivity and sex; and (4) the effects of aging and ghrelin.

2. Peptides That Affect Appetite under Stress

Most appetite-related peptides produced in the digestive tract and released into the blood are appetite-suppressing hormones. Leptin, an anorexic peptide, is produced primarily by adipocytes and acts on the arcuate nucleus of the hypothalamus. Although the coexistence of elevated leptin levels with obesity is widely interpreted as evidence of “leptin resistance”, the relationship between leptin and anorexia nervosa/bulimia has not been completely elucidated. Recently, leptin was shown to control the energy balance between stress and energy metabolism [24]. The secretion of cholecystokinin (CCK), peptide YY (PYY), and glucagon-like peptide 1 (GLP-1) is controlled by sensing lipids and glucose in the digestive tract. Furthermore, the involvement of CCK and PYY under stress has been suggested [25,26,27]. Restraint stress amplified the suppressive effect of CCK on food intake [25]. Foot shock-induced stress resulted in increased CCK levels in the posterior arcuate nucleus. However, notably, stress-induced CCK depletion occurs in the ventromedial and dorsomedial hypothalamic regions [27]. The roles of PYY and GLP-1 in feeding were demonstrated using restraint [26] or water immersion stress [28]. Peripheral PYY and GLP-1 levels increased in mice immersed in water, demonstrating the possibility of a mediating part of the mechanism that reduces feeding in stress models [28]. However, no direct evidence of the role of appetite-suppressing peptides in stress feeding was revealed, and additional verification of the detailed mechanism is warranted.
Kangawa and Kojima [29] discovered ghrelin, an orexigenic hormone localized in the gastric fundus, in 1999. It is the only peripherally produced orexigenic hormone that is a unique peptide with 28 amino acids and an n-octanoyl group. Peripheral ghrelin production and secretion are regulated by hunger status. Ghrelin is secreted into the blood from X/A-like cells in the stomach 1–2 h before daily mealtime, thereby increasing its blood concentration; the secretion decreases by 1 h after the meal, thereby decreasing its blood concentration [30]. Thus, it may play a role in signaling and reporting hunger to the central nervous system (CNS). Ghrelin produced in the gastric mucosa acts on ghrelin receptors located at the ends of the nearby vagus nerve, which transmits these signals to the CNS. The signal via the solitary nucleus (NTS) of the medulla oblongata is an input for the arcuate nucleus of the hypothalamus and transmits an electrical signal to neuropeptide Y (NPY)/agouti-related peptide (AgRP) neurons. In addition, ghrelin promotes the production of peptides, such as NPY and AgRP, and induces appetite [31]. The action of ghrelin may also be affected by anorexic peptides, such as CCK [32]. It has been demonstrated that the ghrelin signal from the periphery is suppressed by the appetite-suppressing signal of peripherally administered CCK during the process of being transmitted to the brain [32]. Ghrelin is also present in trace amounts in the CNS and acts as a neurotransmitter [33,34]. Ghrelin administered to the brain strongly stimulates appetite. It has also been hypothesized that ghrelin released into the periphery permeates the relatively loose regions of the blood–brain barrier, such as the area postrema, and acts directly on the brain. Banks and colleagues also propose the existence of ghrelin transporters in the blood–brain barrier [35]. Thus, ghrelin may act as a neurotransmitter produced in the CNS and a signal from the periphery.
The ghrelin receptor, growth hormone secretagogue receptor 1a (GHS-R1a), is widely distributed in the body, particularly in the hypothalamus, which is the center of appetite, the stress-sensitive amygdala, and the VTA, which is associated with feeding motivation [36,37,38,39]. When subjected to repeated stress, the mechanism that stimulates the reward system becomes overactive, resulting in overeating. GHS-R activation in this region plays a crucial role in binge eating. However, the mechanism of loss of appetite due to acute stress (e.g., pain caused by illness or injury) remains largely unclear. A further challenge is that most of the links between appetite-regulating peptides and stress have been established via basic research using rodents, and there are few clinical studies. Stress susceptibility varies significantly from person to person, and overcoming the precision of peptide quantification, which is susceptible to psychological effects, may lead to further development in this field.

3. Changes in Ghrelin Secretion and Reactivity to Stress

Since the discovery of ghrelin, its association with various diseases has been extensively studied. Recently, it has become clear that attenuated ghrelin signaling plays a vital role in reducing food intake under stress [2,40,41,42]. To date, basic research has demonstrated that blood ghrelin levels are reduced in animal models of a disease that clinically causes anorexia and that exogenous ghrelin supply restores appetite. The administration of drugs, such as anticancer drugs and classic antidepressants, causes various stresses, such as nausea and vomiting, and loss of appetite, leading to reduced treatment compliance. These drugs also deplete ghrelin levels in the body [43,44,45].
Stress is a trigger for diseases that cause psychological abnormalities. We found that a decrease in ghrelin levels was associated with hypophagia after exposure to acute stress. Urocortin is a biological peptide that strongly binds to corticotropin-releasing factor (CRF) 1 and 2 receptors and causes stress-like symptoms. Urocortin intraventricularly administered in rats markedly reduces food intake and blood ghrelin levels [40]. Similar results were observed in mice exposed to restraint stress and immune-associated stress due to lipopolysaccharide injection [46,47]. Strong stressors are transiently loaded in these stress models and have systemic effects. Such stress causes ghrelin depletion in parallel with feeding suppression. In contrast, mice subjected to chronic social defeat and chronic isolation stress demonstrate increased peripheral ghrelin production and food intake compared with unstressed mice [48,49]. However, no weight gain commensurate with increased feeding is observed in mice subjected to chronic isolation. Conversely, in mice immersed in water [28] and those with stress due to a novel environment [42], the peripheral ghrelin level increases after the stress load, but the food intake decreases. This suggests “ghrelin resistance”, signifying the inhibition of the transmission of peripheral ghrelin signals to the CNS. Thus, the resulting change in feeding behavior depends on the type and quality of stress, and may be mediated by abnormal ghrelin dynamics.
Although there is little clinical evidence to clarify the association between stress and ghrelin, Kiessl et al. evaluated food intake and peripheral ghrelin levels before and after acute stress loading using the trier social stress test (TSST) as a stressor. Acute stress suppresses feeding and does not affect blood ghrelin levels [50]. Conversely, Rouach et al. demonstrated that TSST loading increased peripheral ghrelin levels in cortisol responders and that there was a positive association among alterations in ghrelin and cortisol levels [51]. Mckay et al. reported that ghrelin levels in participants were significantly higher after stress compared with the baseline [52]. They concluded that ghrelin is the most likely candidate driving energy intake after stress in humans. Similarly, TSST loading increases ghrelin levels to a greater extent in subjects with dietary restrictions as compared with those with no dietary restrictions, but no significant differences were detected for PYY [53]. These results were consistent with the findings of studies that reported increased peripheral ghrelin in a mouse acute stress model due to water immersion load [28] and novel environmental change load [42]. Thus, clinical trials in which acute stress loading increased peripheral ghrelin levels but reduced appetite were reproducible in several psychological stress models.

4. Relationship between Ghrelin Reactivity and Sex Due to Stress Loading

The main neural responses to stress are the activation of the paraventricular nucleus (PVN) of the hypothalamus and the resulting release of neuropeptides that activate the pituitary gland, CRF, and vasopressin. This activates the hypothalamo–pituitary–adrenal (HPA) axis, which represents the stress feedback mechanism [54,55]. The stress response is influenced by sex, and females are considered more vulnerable than males [56,57]. Additionally, depression and bulimia caused by stress are more prevalent in women [58,59]. Studies on rodents exposed to multiple stressors demonstrated elevated levels of corticosterone (CORT) and adrenocorticotropic hormone (ACTH) in females than in males [60,61]. Following stress, neural activity in the PVN is also high in females [62]. Compared with male rats, female rats have higher levels of arginine vasopressin (AVP) and CRF mRNA expression in the PVN, and higher levels of ACTH precursor proopiomelanocortin (POMC) mRNA in the anterior pituitary gland after induction with acute stressors [63,64]. Additionally, the restoration of ACTH and CORT levels to the baseline after acute stress in female rats is delayed, and female rats are vulnerable to negative feedback regulation of the HPA axis [61,65]. Glucocorticoid binding to target tissues, which play an essential role in negative feedback, is lower in the hypothalamus of female rats than in the hypothalamus of male rats, suggesting that the female hypothalamus has fewer corticosteroid receptors [66]. These findings indicate that the same kind of stress and similar stress load result in differences in subsequent biological reactions in males and females.
Furthermore, the sex differences in the neuroendocrine response to acute stress are partly caused by the interaction between the HPA axis and the hypothalamic–pituitary–gonadal (HPG) axis [67], which controls reproduction. However, the exact mechanism of gonadal hormones on stress response is under investigation. The activation of the HPG axis drives estrogen and androgen production in the testes and ovaries, resulting in physiological changes in the female estrous cycle. Estrogen enhances HPA axis response and promotes negative feedback, whereas estradiol treatment has the opposite effects [68,69]. Estradiol-induced increased CRF, AVP, and POMC gene expression causes HPA axis activation [70,71,72]. However, estrogen exerts the opposite effect on the HPA axis via two receptors. Estrogen receptor (ER) α activation indirectly causes HPA axis activation [73], whereas ERβ acts on the PVN and inhibits HPA axis activity [74,75]. Thus, the regulation of the HPA axis by the two ERs may be influenced by several factors, including stress and the reproductive cycle.
The relationship between feeding and gonadal hormones is relatively widely understood. In rodents, these hormones play important roles in energy intake to maintain homeostasis [76]. This is evident in ovariectomized animals, which have increased food intake, and orchidectomized animals, which have decreased food intake. The supply of each hormone normalizes feeding behavior [77,78]. There is also direct evidence that administering estrogen preparations reduces food intake [76]. However, the effects of gonadal hormones on feeding behavior under stress can be complex.
Studies using psychologically stressed mice have reported various findings. In one study, the mice were acclimated for ≥1 week in group housing and then individually transferred to different cages with new bedding and food. This model showed a mild stress response in male mice, with a slight decrease in food intake that recovered to the same level as the control mice within 3 h after an increase in plasma ghrelin levels [42]. Conversely, the decrease in food intake continued even 6 h after stress loading in female mice, although the peripheral ghrelin levels increased. When CORT levels were used as an index, no sex differences were noted in dynamic CORT level changes due to stress, although females showed higher levels than males [42]. This result suggests that the poststress feedback system may be delayed at a point different from the poststress glucocorticoid production process. Although this appears to be a paradoxical phenomenon, in female mice, ghrelin resistance was observed, indicating that an increase in ghrelin does not lead to feeding behavior due to stress loading.
Assessing responsiveness to exogenous ghrelin is a useful measure for determining ghrelin resistance. When acylated ghrelin is administered to normal mice, they consume more food. Furthermore, normal female mice appear more responsive than male mice to ghrelin [42]. Intraperitoneal administration of 50–500 nmol/kg of acylated ghrelin resulted in an increase in food intake, which persisted for 6 h and 24 h in female mice, but not in male mice [42,79]. Because male mice were used in most studies on ghrelin reactivity in previous reports, this is the first report on the high reactivity of female mice. After ghrelin administration, electrical stimulation of nerves from the NTS to the arcuate nucleus was higher in females than in males, and AgRP gene expression in the hypothalamus was increased. Conversely, stress loading on female mice inhibited strong neural signals post NTS induced by ghrelin administration. This implies that stress can directly affect the NTS, which is the relay point for ghrelin signals. Furthermore, it was confirmed that ERα-expressing nerves were activated in the NTS. ERα activation can inhibit the ghrelin signal. The consequences of acute psychological stress in mice may suggest a potential mechanism of stress-induced feeding suppression in women.
In our previous study, chronic isolation stress for 2 weeks significantly increased food intake in male mice [49]. This increase also resulted in an increase in peripheral ghrelin levels and the gene expression of the orexigenic peptide NPY/AgRP in the hypothalamus. Thus, binge eating in stressed male mice appears to be directly associated with increased peripheral ghrelin production. Interestingly, although stress loading increased feeding in female mice, plasma ghrelin levels were not increased, and upregulation of NPY/AgRP gene expression was not observed in the hypothalamus. Conversely, mRNA levels of the ghrelin precursor preproghrelin were significantly upregulated in the hypothalamus in stress-loaded female mice. Thus, in female mice, stress can increase ghrelin in the brain and directly promote feeding behavior. Alternatively, this may suggest the hypothesis that the mechanism of hyperphagia due to stress has different pathways in males and females. Thus, further verification is needed.

5. Stress-Induced Anorexia in Aged Subjects

5.1. Aging and Feeding

Currently, aging is a difficult challenge faced by developed countries [80,81]. Anorexia due to aging is a common condition in older people and occurs in about 20% of the older population [82]. Anorexia due to aging is defined as an age-related loss of appetite and food intake. It is also observed in healthy older adults without illnesses, and occurs even in those with an adequate food supply [83,84]. Loss of appetite can lead to protein–energy malnutrition and weight loss. In older adults, these are associated with several health conditions, including increased mortality [85]. The main causes of loss of appetite in this population, for example, the social environment and background in isolation from family, should be comprehensively evaluated. However, in terms of physiological aspects, the accepted concept states that energy consumption and supply demands decrease with age [86]. Additionally, abnormalities in the appetite-promoting or inhibitory satiety signals that regulate feeding may occur. For example, appetite-suppressing signals predominate in healthy older subjects more than in younger subjects, contributing to sustained satiety and hunger suppression [87].
Leptin and CCK, which are appetite-suppressing hormones, are also affected by aging. Animal studies have shown that centrally administered leptin induces anorexia and reduces fever effects in obese older rats [88]. However, clinical evidence on peripheral leptin levels in the elderly population varies. Although one study reported no difference in leptin levels among older patients with or without anorexia [82], another reported that leptin levels increased in middle-aged women and decreased in older women [89]. Additionally, leptin reportedly improves the satiety effect of cholecystokinin octapeptide (CCK-8) in aged animals [90]. This effect has also been observed in older individuals [91,92]. CCK levels increase with age in both animals [93] and humans [94]. Moreover, increased feeding behavior due to exogenous ghrelin administration is absent in aged mice compared with younger ones, and these mice also lack diurnal variation in peripheral ghrelin levels [95]. In humans, circulating ghrelin levels are lower in older adults than in young adults [96], but some studies have reported no difference [97]. Older individuals also have lower acylated ghrelin levels than deacylated des-acyl ghrelin levels [98]. Acylated ghrelin has a short half-life and is rapidly deacylated in circulation, leading to the formation of inactive des-acyl ghrelin. The difficulty of measuring ghrelin in clinical practice may explain the differences in these findings regarding ghrelin. Therefore, after blood collection, the inactivation of an acylated ghrelin-degrading enzyme is required as soon as possible within a predetermined time frame (acylated ghrelin has a half-life of about 10 min).

5.2. Aging and Stress

Compared with younger adults, older people have different biological reactions due to stressors. In older people, physical degeneration and illnesses accompanying aging may amplify the stress response [99]. As a result, anxiety and depression in this population are qualitatively different from those experienced by younger people, and disorders commonly resultant from aging, such as apathy, cognitive impairment, and sleep disorders, may overlap [81,100]. These disorders may indicate that the combination of aging and stress makes central functions more vulnerable.
For recovery from stress, glucocorticoids induced by HPA axis activation suppress and inhibit the production of CRF, AVP, and ACTH. The secretion of the most important endogenous glucocorticoid in the HPA axis has a constant diurnal rhythm, increases after waking up, and then slowly decreases in the evening [101,102]. Therefore, examining the diurnal variation of cortisol helps assess HPA axis activation. In rodents, some factors, including old age and recurrent stress [103], reduced glucocorticoid receptor (GR) reactivity [104,105]. When this occurs, the negative feedback on the HPA axis is reduced, resulting in the maintenance of high cortisol levels. Therefore, HPA axis dysregulation occurs in older adults, indicating that the HPA axis is vulnerable. Alterations in morning cortisol levels or the measurement of a cortisol-awakening response (CAR) are good indicators of HPA axis vulnerability in humans [106], and are flatter from morning to evening. A cortisol gradient has also been reported [107]. Almeida et al. [108] reported that older men had considerably higher CAR compared with younger men, whereas the effect of age in women was insignificant. This result also suggests that there are sex differences in age-related abnormal cortisol secretion.
Abnormal cortisol secretion in older adults can have serious clinical consequences. For example, overactivation of the HPA axis and hypersecretion of glucocorticoids can cause atrophy of the dendrites of hippocampal neurons, which can impair learning and memory functions, decision making, and emotional responses [109]. It has also been reported that glucocorticoids play a causal role in aging and age-related disorders [110] and speculated that the risk of developing neuropsychiatric disorders with aging increases. Persistent glucocorticoid elevation may also be associated with decreased reactivity in the GR on the HPA axis. Decreased levels and binding of the GR in the hippocampus and prefrontal cortex (PFC) have been demonstrated previously in aged animals [104,105]. For example, impaired feedback due to glucocorticoid inhibition impairs the GR in the hippocampus, PFC, and PVN in aged rats. Furthermore, it is associated with the inhibition of the GR translocation into the nucleus [104,105]. Thus, aging may cause a decline in GR function in the hippocampus, PFC, and PVN. In contrast, chronic stress and treatment with CORT do not cause cell death in the hippocampus of several animals, including humans [111,112]. These contradictory results are still being discussed.

5.3. Aging, Stress, and Feeding

There are few studies on stress and feeding in older adults. So far, psychological stress models in aged mice, such as novel environmental stress, have been used to demonstrate an increase in blood CORT levels and a decrease in feeding as compared with young mice [113]. Interestingly, in aged mice subjected to novel environmental stress loading, a decrease in the bout number was noted, as was a consistent decrease in meal amount and size. In normal-aged mice, one bout is originally small when feeding, but the number of bouts increases to maintain the daily feeding amount. It is assumed that, compared with young mice, older mice find it difficult to bite and eat large amounts of food at one time. In contrast, stress loading on aged mice reduces the increase in bout numbers, which is a typical feeding pattern. Thus, stress loading reduces food intake in aged mice and alters the feeding pattern itself. In studies on water-avoidance stress models using aged mice, there was a decrease in dark-term locomotor activity and an alteration in feeding behavior [19].
Glucocorticoids promote appetite in the short term [114,115,116,117]. However, the effect of chronic glucocorticoid exposure, which is a characteristic of stress loading in older adults, on appetite has not been fully investigated. High circulating ACTH levels reduce flavor cravings, and high cortisol levels reduce postprandial satisfaction and satiety in patients with Cushing’s syndrome. However, there seems to be no difference in hunger, fullness, and satisfaction between the fasting and fed conditions [118]. Fasting and postprandial circulating ghrelin levels are increased in those with Cushing’s syndrome because glucocorticoids stimulate the expression of ghrelin and its receptor [119,120,121]. Furthermore, no relationship was found between fasting or postprandial ghrelin levels and appetite or thirst scores. These findings may evince that chronic glucocorticoid exposure is a part of ghrelin-mediated appetite abnormalities in older adults.
The persistent reduction in feeding behavior during acute stress loading in aged mice appears to be mediated by complex networks in the periphery and brain. One may involve increased sensitivity of serotonin 2C receptors (5-HT2CR) in the brain [113,122,123]. 5-HT2CR is a receptor primarily involved in anxiogenic and feeding control [124,125], and intraperitoneal or intracerebroventricular administration of the 5-HT2CR stimulant m-chlorophenylpiperazine (mCPP) reduces food intake [43,113] while simultaneously reducing peripheral ghrelin secretion [43]. As previously reported, the intraperitoneal administration of mCPP in mice reduces food intake and appears to have a stronger effect in aged mice than in younger ones. Conclusively, the administration of 5-HT2CR antagonists almost reverses the persistent decrease in feeding and the increase in the HPA axis due to stress loading in aged mice [113,122]. Although the mechanism is not completely clear, 5-HT2CR mRNA expression in the hypothalamus, which receives peripheral hunger signals, is significantly enhanced by stress loading in aged mice [113]. The number of 5-HT2CR-expressing cells also increases in aged mice. The increased production of 5-HT2CR in the brain may play an important role in stress-bearing vulnerability in aged mice. Because ghrelin kinetics are abnormal in normal older mice [95], stress loading on older adults is expected to cause complex biological reactions. It is speculated that aged mice with high sensitivity to 5-HT2CR have a more pronounced decrease in ghrelin than young mice, but appropriate comparative studies investigating this have not been conducted so far. Further stress loading should cause highly complex biological reactions. On the other hand, chronic stress-induced binge eating observed in young mice was not seen in aged mice. Changes in stress response with aging appear to differ between acute and chronic stresses.
There are few studies on sex differences in older adults under stress load. We suggest that, compared with aged female mice, aged male mice are extremely vulnerable to stress [122,123]. The results of novel environmental stress loading revealed a sustained decrease in food intake and hyperactivity of the HPA axis in aged male mice. However, the exposure of aged female mice to stress on a similar schedule results in no sustained response. This may be related to clinical findings demonstrating that HPA axis abnormalities with age are absent in women [108]. Additionally, stress-loaded aged female mice have lower neural activity in the amygdala and PVN than males, and do not show overactivation of the HPA axis; further, the intraperitoneal administration of mCPP does not show as much responsiveness in female mice as in male mice [122]. Compared with young mice, aged male mice demonstrate the overexpression of 5-HT2CR, but female mice do not demonstrate the hyperactivity of 5-HT2CR-positive neurons with aging. The decrease in peripheral ghrelin levels in aged male mice is not observed in female mice. Compared with aged female mice, male mice tend to have higher mRNA expression of ERα, ERβ, and aromatase in the hypothalamus under normal conditions. Furthermore, it has been demonstrated that male mice are more sensitive to stimulants of the ERα rather than ERβ, but females are less sensitive than males to the same [122]. Further studies are needed to determine the direct relationship between ERα activation and reduced feeding through 5-HT2CR activation.

6. Conclusions

Stress affects eating behavior, a basic but important activity. A complex network of appetite-related peptides controls appetite. When multiple factors, such as disease complications, sex differences, and aging, are involved, appetite control becomes more complex. Thus, at present, it remains challenging to completely understand appetite control. For example, the orexigenic peptide, ghrelin, mediates stress-induced eating disorders by abnormal secretion and signal transduction. Disturbances in ghrelin signals are also influenced by aging and sex. Sex differences also regulate ghrelin responsiveness, and aging triggers a persistent stress response (Figure 1). However, overeating due to chronic stress does not occur with aging (Figure 2). Further research on each reactivity according to each type of stress is warranted.
Acute stress rapidly activates the HPA axis, inducing the negative feedback system for stress. Simultaneously, stress causes abnormal ghrelin secretion, consequently leading to anorexia. It is considered that the mechanism of ghrelin dysfunction varies depending on the sex. In females, ERα causes dysregulation of the HPA axis negative feedback. ERα activation may be involved in the induction of ghrelin resistance. Aging results in the aberrant activation of serotonin 2C receptors under stress in male mice, leading to the disruption of the negative feedback system of the HPA axis and amplification of stress-induced biological responses. Aberrant activation of serotonin 2C receptors in the central nervous system is unlikely to occur in aged female mice.
Chronic stress continuously activates the HPA axis, which enhances ghrelin secretion (or reaction enhancement) in the brain, thereby stimulating the reward system, which could lead to increased feeding. Such enhancement may not occur in aged mice.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

References

  1. Halataei, B.A.; Khosravi, M.; Arbabian, S.; Sahraei, H.; Golmanesh, L.; Zardooz, H.; Jalili, C.; Ghoshooni, H. Saffron (Crocus sativus) aqueous extract and its constituent crocin reduces stress-induced anorexia in mice. Phytother. Res. 2011, 25, 1833–1838. [Google Scholar] [CrossRef]
  2. Saegusa, Y.; Takeda, H.; Muto, S.; Nakagawa, K.; Ohnishi, S.; Sadakane, C.; Nahata, M.; Hattori, T.; Asaka, M. Decreased plasma ghrelin contributes to anorexia following novelty stress. Am. J. Physiol. Endocrinol. Metab. 2011, 301, E685–E696. [Google Scholar] [CrossRef]
  3. Monnikes, H.; Tebbe, J.J.; Hildebrandt, M.; Arck, P.; Osmanoglou, E.; Rose, M.; Klapp, B.; Wiedenmann, B.; Heymann-Monnikes, I. Role of stress in functional gastrointestinal disorders. Evidence for stress-induced alterations in gastrointestinal motility and sensitivity. Dig. Dis. 2001, 19, 201–211. [Google Scholar] [CrossRef]
  4. Nahata, M.; Saegusa, Y.; Sadakane, C.; Yamada, C.; Nakagawa, K.; Okubo, N.; Ohnishi, S.; Hattori, T.; Sakamoto, N.; Takeda, H. Administration of exogenous acylated ghrelin or rikkunshito, an endogenous ghrelin enhancer, improves the decrease in postprandial gastric motility in an acute restraint stress mouse model. Neurogastroenterol. Motil. 2014, 26, 821–831. [Google Scholar] [CrossRef] [PubMed]
  5. Collins, S.M. Stress and the Gastrointestinal Tract IV. Modulation of intestinal inflammation by stress: Basic mechanisms and clinical relevance. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280, G315–G318. [Google Scholar] [CrossRef]
  6. Charmandari, E.; Tsigos, C.; Chrousos, G. Endocrinology of the stress response. Annu. Rev. Physiol. 2005, 67, 259–284. [Google Scholar] [CrossRef]
  7. Peterson, C.B.; Thuras, P.; Ackard, D.M.; Mitchell, J.E.; Berg, K.; Sandager, N.; Wonderlich, S.A.; Pederson, M.W.; Crow, S.J. Personality dimensions in bulimia nervosa, binge eating disorder, and obesity. Compr. Psychiatry 2010, 51, 31–36. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Sassaroli, S.; Fiore, F.; Mezzaluna, C.; Ruggiero, G.M. Stressful task increases drive for thinness and bulimia: A laboratory study. Front. Psychol. 2015, 6, 591. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Yaribeygi, H.; Panahi, Y.; Sahraei, H.; Johnston, T.P.; Sahebkar, A. The impact of stress on body function: A review. EXCLI J. 2017, 16, 1057–1072. [Google Scholar] [CrossRef] [PubMed]
  10. Lupien, S.J.; Lepage, M. Stress, memory, and the hippocampus: Can’t live with it, can’t live without it. Behav. Brain Res. 2001, 127, 137–158. [Google Scholar] [CrossRef]
  11. Shields, G.S.; Sazma, M.A.; McCullough, A.M.; Yonelinas, A.P. The effects of acute stress on episodic memory: A meta-analysis and integrative review. Psychol. Bull. 2017, 143, 636–675. [Google Scholar] [CrossRef] [PubMed]
  12. Zellner, D.A.; Loaiza, S.; Gonzalez, Z.; Pita, J.; Morales, J.; Pecora, D.; Wolf, A. Food selection changes under stress. Physiol. Behav. 2006, 87, 789–793. [Google Scholar] [CrossRef] [PubMed]
  13. Adam, T.C.; Epel, E.S. Stress, eating and the reward system. Physiol. Behav. 2007, 91, 449–458. [Google Scholar] [CrossRef] [PubMed]
  14. Ely, D.R.; Dapper, V.; Marasca, J.; Correa, J.B.; Gamaro, G.D.; Xavier, M.H.; Michalowski, M.B.; Catelli, D.; Rosat, R.; Ferreira, M.B.; et al. Effect of restraint stress on feeding behavior of rats. Physiol. Behav. 1997, 61, 395–398. [Google Scholar] [CrossRef]
  15. Duarte, P.A.S.; Palmeira, L.; Pinto-Gouveia, J. The Three-Factor Eating Questionnaire-R21: A confirmatory factor analysis in a Portuguese sample. Eat. Weight Disord. 2020, 25, 247–256. [Google Scholar] [CrossRef]
  16. Godleski, S.; Lohse, B.; Krall, J.S. Satter Eating Competence Inventory Subscale Restructure After Confirmatory Factor Analysis. J. Nutr. Educ. Behav. 2019, 51, 1003–1010. [Google Scholar] [CrossRef]
  17. Nielsen, M.G.; Ornbol, E.; Vestergaard, M.; Bech, P.; Larsen, F.B.; Lasgaard, M.; Christensen, K.S. The construct validity of the Perceived Stress Scale. J. Psychosom. Res. 2016, 84, 22–30. [Google Scholar] [CrossRef]
  18. Arble, D.M.; Bass, J.; Laposky, A.D.; Vitaterna, M.H.; Turek, F.W. Circadian timing of food intake contributes to weight gain. Obesity 2009, 17, 2100–2102. [Google Scholar] [CrossRef]
  19. Yamada, C.; Mogami, S.; Hattori, T. Psychological stress exposure to aged mice causes abnormal feeding patterns with changes in the bout number. Aging 2017, 9, 2269–2287. [Google Scholar] [CrossRef] [Green Version]
  20. Bechtholt, A.J.; Hill, T.E.; Lucki, I. Anxiolytic effect of serotonin depletion in the novelty-induced hypophagia test. Psychopharmacology 2007, 190, 531–540. [Google Scholar] [CrossRef]
  21. Wang, L.; Mogami, S.; Yakabi, S.; Karasawa, H.; Yamada, C.; Yakabi, K.; Hattori, T.; Tache, Y. Patterns of Brain Activation and Meal Reduction Induced by Abdominal Surgery in Mice and Modulation by Rikkunshito. PLoS ONE 2015, 10, e0139325. [Google Scholar] [CrossRef] [Green Version]
  22. Mogami, S.; Yamada, C.; Fujitsuka, N.; Hattori, T. Peptide YY induces characteristic meal patterns of aged mice. Horm. Behav. 2017, 96, 62–68. [Google Scholar] [CrossRef]
  23. Frank, G.K. Advances from neuroimaging studies in eating disorders. CNS Spectr. 2015, 20, 391–400. [Google Scholar] [CrossRef] [PubMed]
  24. Haleem, D.J. Investigations into the involvement of leptin in responses to stress. Behav. Pharmacol. 2014, 25, 384–397. [Google Scholar] [CrossRef]
  25. Yamaguchi, N.; Hosomi, E.; Hori, Y.; Ro, S.; Maezawa, K.; Ochiai, M.; Nagoshi, S.; Takayama, K.; Yakabi, K. The Combination of Cholecystokinin and Stress Amplifies an Inhibition of Appetite, Gastric Emptying, and an Increase in c-Fos Expression in Neurons of the Hypothalamus and the Medulla Oblongata. Neurochem. Res. 2020, 45, 2173–2183. [Google Scholar] [CrossRef] [PubMed]
  26. Forbes, S.C.; Cox, H.M. Peptide YY, neuropeptide Y and corticotrophin-releasing factor modulate gastrointestinal motility and food intake during acute stress. Neurogastroenterol. Motil. 2014, 26, 1605–1614. [Google Scholar] [CrossRef] [PubMed]
  27. Siegel, R.A.; Duker, E.M.; Pahnke, U.; Wuttke, W. Stress-induced changes in cholecystokinin and substance P concentrations in discrete regions of the rat hypothalamus. Neuroendocrinology 1987, 46, 75–81. [Google Scholar] [CrossRef] [PubMed]
  28. Yamada, C.; Mogami, S.; Kanno, H.; Hattori, T. Peptide YY Causes Apathy-Like Behavior via the Dopamine D2 Receptor in Repeated Water-Immersed Mice. Mol. Neurobiol. 2018, 55, 7555–7566. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Kojima, M.; Hosoda, H.; Date, Y.; Nakazato, M.; Matsuo, H.; Kangawa, K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402, 656–660. [Google Scholar] [CrossRef]
  30. Cummings, D.E.; Purnell, J.Q.; Frayo, R.S.; Schmidova, K.; Wisse, B.E.; Weigle, D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001, 50, 1714–1719. [Google Scholar] [CrossRef] [Green Version]
  31. Cowley, M.A.; Smith, R.G.; Diano, S.; Tschop, M.; Pronchuk, N.; Grove, K.L.; Strasburger, C.J.; Bidlingmaier, M.; Esterman, M.; Heiman, M.L.; et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003, 37, 649–661. [Google Scholar] [CrossRef] [Green Version]
  32. Kobelt, P.; Tebbe, J.J.; Tjandra, I.; Stengel, A.; Bae, H.G.; Andresen, V.; van der Voort, I.R.; Veh, R.W.; Werner, C.R.; Klapp, B.F.; et al. CCK inhibits the orexigenic effect of peripheral ghrelin. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288, R751–R758. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Gnanapavan, S.; Kola, B.; Bustin, S.A.; Morris, D.G.; McGee, P.; Fairclough, P.; Bhattacharya, S.; Carpenter, R.; Grossman, A.B.; Korbonits, M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab. 2002, 87, 2988. [Google Scholar] [CrossRef] [PubMed]
  34. Stengel, A.; Goebel, M.; Wang, L.; Tache, Y. Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: Role as regulators of food intake and body weight. Peptides 2010, 31, 357–369. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Banks, W.A. The blood-brain barrier: Connecting the gut and the brain. Regul. Pept. 2008, 149, 11–14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Zigman, J.M.; Jones, J.E.; Lee, C.E.; Saper, C.B.; Elmquist, J.K. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J. Comp. Neurol. 2006, 494, 528–548. [Google Scholar] [CrossRef] [Green Version]
  37. Abizaid, A.; Liu, Z.W.; Andrews, Z.B.; Shanabrough, M.; Borok, E.; Elsworth, J.D.; Roth, R.H.; Sleeman, M.W.; Picciotto, M.R.; Tschop, M.H.; et al. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J. Clin. Investig. 2006, 116, 3229–3239. [Google Scholar] [CrossRef] [PubMed]
  38. Andrews, Z.B. The extra-hypothalamic actions of ghrelin on neuronal function. Trends Neurosci. 2011, 34, 31–40. [Google Scholar] [CrossRef]
  39. Harmatz, E.S.; Stone, L.; Lim, S.H.; Lee, G.; McGrath, A.; Gisabella, B.; Peng, X.; Kosoy, E.; Yao, J.; Liu, E.; et al. Central Ghrelin Resistance Permits the Overconsolidation of Fear Memory. Biol. Psychiatry 2017, 81, 1003–1013. [Google Scholar] [CrossRef]
  40. Harada, Y.; Takayama, K.; Ro, S.; Ochiai, M.; Noguchi, M.; Iizuka, S.; Hattori, T.; Yakabi, K. Urocortin1-induced anorexia is regulated by activation of the serotonin 2C receptor in the brain. Peptides 2014, 51, 139–144. [Google Scholar] [CrossRef] [Green Version]
  41. Yamada, C.; Saegusa, Y.; Nakagawa, K.; Ohnishi, S.; Muto, S.; Nahata, M.; Sadakane, C.; Hattori, T.; Sakamoto, N.; Takeda, H. Rikkunshito, a Japanese kampo medicine, ameliorates decreased feeding behavior via ghrelin and serotonin 2B receptor signaling in a novelty stress murine model. Biomed. Res. Int. 2013, 2013, 792940. [Google Scholar] [CrossRef]
  42. Yamada, C.; Iizuka, S.; Nahata, M.; Hattori, T.; Takeda, H. Vulnerability to psychological stress-induced anorexia in female mice depends on blockade of ghrelin signal in nucleus tractus solitarius. Br. J. Pharmacol. 2020, 177, 4666–4682. [Google Scholar] [CrossRef]
  43. Takeda, H.; Sadakane, C.; Hattori, T.; Katsurada, T.; Ohkawara, T.; Nagai, K.; Asaka, M. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology 2008, 134, 2004–2013. [Google Scholar] [CrossRef]
  44. Fujitsuka, N.; Asakawa, A.; Hayashi, M.; Sameshima, M.; Amitani, H.; Kojima, S.; Fujimiya, M.; Inui, A. Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin. Biol. Psychiatry 2009, 65, 748–759. [Google Scholar] [CrossRef]
  45. Yakabi, K.; Sadakane, C.; Noguchi, M.; Ohno, S.; Ro, S.; Chinen, K.; Aoyama, T.; Sakurada, T.; Takabayashi, H.; Hattori, T. Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia. Endocrinology 2010, 151, 3773–3782. [Google Scholar] [CrossRef] [Green Version]
  46. Jeong, J.Y.; Lee, D.H.; Kang, S.S. Effects of chronic restraint stress on body weight, food intake, and hypothalamic gene expressions in mice. Endocrinol. Metab. 2013, 28, 288–296. [Google Scholar] [CrossRef]
  47. Wang, L.; Basa, N.R.; Shaikh, A.; Luckey, A.; Heber, D.; St-Pierre, D.H.; Tache, Y. LPS inhibits fasted plasma ghrelin levels in rats: Role of IL-1 and PGs and functional implications. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 291, G611–G620. [Google Scholar] [CrossRef]
  48. Lutter, M.; Sakata, I.; Osborne-Lawrence, S.; Rovinsky, S.A.; Anderson, J.G.; Jung, S.; Birnbaum, S.; Yanagisawa, M.; Elmquist, J.K.; Nestler, E.J.; et al. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat. Neurosci. 2008, 11, 752–753. [Google Scholar] [CrossRef] [Green Version]
  49. Yamada, C.; Saegusa, Y.; Nahata, M.; Sadakane, C.; Hattori, T.; Takeda, H. Influence of Aging and Gender Differences on Feeding Behavior and Ghrelin-Related Factors during Social Isolation in Mice. PLoS ONE 2015, 10, e0140094. [Google Scholar] [CrossRef]
  50. Kiessl, G.R.R.; Laessle, R.G. Stress does not affect ghrelin secretion in obese and normal weight women. Eat. Weight Disord. 2017, 22, 79–84. [Google Scholar] [CrossRef]
  51. Rouach, V.; Bloch, M.; Rosenberg, N.; Gilad, S.; Limor, R.; Stern, N.; Greenman, Y. The acute ghrelin response to a psychological stress challenge does not predict the post-stress urge to eat. Psychoneuroendocrinology 2007, 32, 693–702. [Google Scholar] [CrossRef]
  52. McKay, N.J.; Giorgianni, N.R.; Czajka, K.E.; Brzyski, M.G.; Lewandowski, C.L.; Hales, M.L.; Sequeira, I.K.; Bernardo, M.B.; Mietlicki-Baase, E.G. Plasma levels of ghrelin and GLP-1, but not leptin or amylin, respond to a psychosocial stressor in women and men. Horm. Behav. 2021, 134, 105017. [Google Scholar] [CrossRef]
  53. Hilterscheid, E.; Laessle, R. Stress-induced release of GUT peptides in young women classified as restrained or unrestrained eaters. Eat. Weight Disord. 2015, 20, 435–439. [Google Scholar] [CrossRef]
  54. Chrousos, G.P. Stress and disorders of the stress system. Nat. Rev. Endocrinol. 2009, 5, 374–381. [Google Scholar] [CrossRef]
  55. Aguilera, G.; Liu, Y. The molecular physiology of CRH neurons. Front. Neuroendocrinol. 2012, 33, 67–84. [Google Scholar] [CrossRef] [Green Version]
  56. Oyola, M.G.; Handa, R.J. Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal axes: Sex differences in regulation of stress responsivity. Stress 2017, 20, 476–494. [Google Scholar] [CrossRef]
  57. Bangasser, D.A.; Wiersielis, K.R. Sex differences in stress responses: A critical role for corticotropin-releasing factor. Hormones 2018, 17, 5–13. [Google Scholar] [CrossRef] [Green Version]
  58. Ehlert, U.; Gaab, J.; Heinrichs, M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: The role of the hypothalamus-pituitary-adrenal axis. Biol. Psychol. 2001, 57, 141–152. [Google Scholar] [CrossRef]
  59. Kornstein, S.G. Gender differences in depression: Implications for treatment. J. Clin. Psychiatry 1997, 58 (Suppl. 15), 12–18. [Google Scholar]
  60. Handa, R.J.; Burgess, L.H.; Kerr, J.E.; O’Keefe, J.A. Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Horm. Behav. 1994, 28, 464–476. [Google Scholar] [CrossRef]
  61. Viau, V.; Bingham, B.; Davis, J.; Lee, P.; Wong, M. Gender and puberty interact on the stress-induced activation of parvocellular neurosecretory neurons and corticotropin-releasing hormone messenger ribonucleic acid expression in the rat. Endocrinology 2005, 146, 137–146. [Google Scholar] [CrossRef]
  62. Larkin, J.W.; Binks, S.L.; Li, Y.; Selvage, D. The role of oestradiol in sexually dimorphic hypothalamic-pituitary-adrena axis responses to intracerebroventricular ethanol administration in the rat. J. Neuroendocrinol. 2010, 22, 24–32. [Google Scholar] [CrossRef] [Green Version]
  63. Babb, J.A.; Masini, C.V.; Day, H.E.; Campeau, S. Sex differences in activated corticotropin-releasing factor neurons within stress-related neurocircuitry and hypothalamic-pituitary-adrenocortical axis hormones following restraint in rats. Neuroscience 2013, 234, 40–52. [Google Scholar] [CrossRef] [Green Version]
  64. Seale, J.V.; Wood, S.A.; Atkinson, H.C.; Bate, E.; Lightman, S.L.; Ingram, C.D.; Jessop, D.S.; Harbuz, M.S. Gonadectomy reverses the sexually diergic patterns of circadian and stress-induced hypothalamic-pituitary-adrenal axis activity in male and female rats. J. Neuroendocrinol. 2004, 16, 516–524. [Google Scholar] [CrossRef]
  65. Iwasaki-Sekino, A.; Mano-Otagiri, A.; Ohata, H.; Yamauchi, N.; Shibasaki, T. Gender differences in corticotropin and corticosterone secretion and corticotropin-releasing factor mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats. Psychoneuroendocrinology 2009, 34, 226–237. [Google Scholar] [CrossRef]
  66. Turner, B.B.; Weaver, D.A. Sexual dimorphism of glucocorticoid binding in rat brain. Brain Res. 1985, 343, 16–23. [Google Scholar] [CrossRef]
  67. Viau, V. Functional cross-talk between the hypothalamic-pituitary-gonadal and -adrenal axes. J. Neuroendocrinol. 2002, 14, 506–513. [Google Scholar] [CrossRef]
  68. Ochedalski, T.; Subburaju, S.; Wynn, P.C.; Aguilera, G. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity. J. Neuroendocrinol. 2007, 19, 189–197. [Google Scholar] [CrossRef]
  69. Young, E.A.; Altemus, M.; Parkison, V.; Shastry, S. Effects of estrogen antagonists and agonists on the ACTH response to restraint stress in female rats. Neuropsychopharmacology 2001, 25, 881–891. [Google Scholar] [CrossRef]
  70. Seale, J.V.; Wood, S.A.; Atkinson, H.C.; Harbuz, M.S.; Lightman, S.L. Gonadal steroid replacement reverses gonadectomy-induced changes in the corticosterone pulse profile and stress-induced hypothalamic-pituitary-adrenal axis activity of male and female rats. J. Neuroendocrinol. 2004, 16, 989–998. [Google Scholar] [CrossRef]
  71. Lunga, P.; Herbert, J. 17Beta-oestradiol modulates glucocorticoid, neural and behavioural adaptations to repeated restraint stress in female rats. J. Neuroendocrinol. 2004, 16, 776–785. [Google Scholar] [CrossRef] [Green Version]
  72. Kitay, J.I. Pituitary-Adrenal Function in the Rat after Gonadectomy and Gonadal Hormone Replacement. Endocrinology 1963, 73, 253–260. [Google Scholar] [CrossRef]
  73. Handa, R.J.; Weiser, M.J. Gonadal steroid hormones and the hypothalamo-pituitary-adrenal axis. Front. Neuroendocrinol. 2014, 35, 197–220. [Google Scholar] [CrossRef] [Green Version]
  74. Weiser, M.J.; Handa, R.J. Estrogen impairs glucocorticoid dependent negative feedback on the hypothalamic-pituitary-adrenal axis via estrogen receptor alpha within the hypothalamus. Neuroscience 2009, 159, 883–895. [Google Scholar] [CrossRef]
  75. Lund, T.D.; Hinds, L.R.; Handa, R.J. The androgen 5alpha-dihydrotestosterone and its metabolite 5alpha-androstan-3beta, 17beta-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor beta-expressing neurons in the hypothalamus. J. Neurosci. 2006, 26, 1448–1456. [Google Scholar] [CrossRef] [Green Version]
  76. Asarian, L.; Geary, N. Sex differences in the physiology of eating. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013, 305, R1215–R1267. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Asarian, L.; Geary, N. Cyclic estradiol treatment normalizes body weight and restores physiological patterns of spontaneous feeding and sexual receptivity in ovariectomized rats. Horm. Behav. 2002, 42, 461–471. [Google Scholar] [CrossRef]
  78. Asarian, L.; Geary, N. Modulation of appetite by gonadal steroid hormones. Philos. Trans. R. Soc. B Biol. Sci. 2006, 361, 1251–1263. [Google Scholar] [CrossRef] [Green Version]
  79. Yamada, C. Relationship between Orexigenic Peptide Ghrelin Signal, Gender Difference and Disease. Int. J. Mol. Sci. 2021, 22, 3763. [Google Scholar] [CrossRef]
  80. Lima, M.G.; Barros, M.B.; Cesar, C.L.; Goldbaum, M.; Carandina, L.; Ciconelli, R.M. Health related quality of life among the elderly: A population-based study using SF-36 survey. Cadernos de Saúde Pública 2009, 25, 2159–2167. [Google Scholar] [CrossRef] [PubMed]
  81. Flint, A.J. Generalised anxiety disorder in elderly patients: Epidemiology, diagnosis and treatment options. Drugs Aging 2005, 22, 101–114. [Google Scholar] [CrossRef]
  82. Donini, L.M.; Poggiogalle, E.; Piredda, M.; Pinto, A.; Barbagallo, M.; Cucinotta, D.; Sergi, G. Anorexia and eating patterns in the elderly. PLoS ONE 2013, 8, e63539. [Google Scholar] [CrossRef] [Green Version]
  83. Rolls, B.J.; Dimeo, K.A.; Shide, D.J. Age-related impairments in the regulation of food intake. Am. J. Clin. Nutr. 1995, 62, 923–931. [Google Scholar] [CrossRef]
  84. Wurtman, J.J. The anorexia of aging: A problem not restricted to calorie intake. Neurobiol. Aging 1988, 9, 22–23. [Google Scholar] [CrossRef]
  85. Soenen, S.; Chapman, I.M. Body weight, anorexia, and undernutrition in older people. J. Am. Med. Dir. Assoc. 2013, 14, 642–648. [Google Scholar] [CrossRef] [PubMed]
  86. De Boer, A.; Ter Horst, G.J.; Lorist, M.M. Physiological and psychosocial age-related changes associated with reduced food intake in older persons. Ageing Res. Rev. 2013, 12, 316–328. [Google Scholar] [CrossRef]
  87. Di Francesco, V.; Zamboni, M.; Zoico, E.; Mazzali, G.; Dioli, A.; Omizzolo, F.; Bissoli, L.; Fantin, F.; Rizzotti, P.; Solerte, S.B.; et al. Unbalanced serum leptin and ghrelin dynamics prolong postprandial satiety and inhibit hunger in healthy elderly: Another reason for the “anorexia of aging”. Am. J. Clin. Nutr. 2006, 83, 1149–1152. [Google Scholar] [CrossRef] [Green Version]
  88. Shek, E.W.; Scarpace, P.J. Resistance to the anorexic and thermogenic effects of centrally administrated leptin in obese aged rats. Regul. Pept. 2000, 92, 65–71. [Google Scholar] [CrossRef]
  89. Perry, H.M., III; Morley, J.E.; Horowitz, M.; Kaiser, F.E.; Miller, D.K.; Wittert, G. Body composition and age in African-American and Caucasian women: Relationship to plasma leptin levels. Metabolism 1997, 46, 1399–1405. [Google Scholar] [CrossRef]
  90. Silver, A.J.; Flood, J.F.; Morley, J.E. Effect of gastrointestinal peptides on ingestion in old and young mice. Peptides 1988, 9, 221–225. [Google Scholar] [CrossRef]
  91. Chapman, I.M.; MacIntosh, C.G.; Morley, J.E.; Horowitz, M. The anorexia of ageing. Biogerontology 2002, 3, 67–71. [Google Scholar] [CrossRef]
  92. Tai, K.; Feinle-Bisset, C.; Horowitz, M.; Wishart, J.M.; Chapman, I.M. Effects of nutritional supplementation on the appetite and energy intake responses to IV cholecystokinin in older adults. Appetite 2010, 55, 473–477. [Google Scholar] [CrossRef]
  93. Miyasaka, K.; Kanai, S.; Masuda, M.; Ohta, M.; Kawanami, T.; Matsumoto, M.; Funakoshi, A. Gene expressions of cholecystokinin (CCK) and CCK receptors, and its satiety effect in young and old male rats. Arch. Gerontol. Geriatr. 1995, 21, 147–155. [Google Scholar] [CrossRef]
  94. Sturm, K.; MacIntosh, C.G.; Parker, B.A.; Wishart, J.; Horowitz, M.; Chapman, I.M. Appetite, food intake, and plasma concentrations of cholecystokinin, ghrelin, and other gastrointestinal hormones in undernourished older women and well-nourished young and older women. J. Clin. Endocrinol. Metab. 2003, 88, 3747–3755. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  95. Takeda, H.; Muto, S.; Hattori, T.; Sadakane, C.; Tsuchiya, K.; Katsurada, T.; Ohkawara, T.; Oridate, N.; Asaka, M. Rikkunshito ameliorates the aging-associated decrease in ghrelin receptor reactivity via phosphodiesterase III inhibition. Endocrinology 2010, 151, 244–252. [Google Scholar] [CrossRef] [Green Version]
  96. Schneider, S.M.; Al-Jaouni, R.; Caruba, C.; Giudicelli, J.; Arab, K.; Suavet, F.; Ferrari, P.; Mothe-Satney, I.; Van Obberghen, E.; Hebuterne, X. Effects of age, malnutrition and refeeding on the expression and secretion of ghrelin. Clin. Nutr. 2008, 27, 724–731. [Google Scholar] [CrossRef]
  97. Vilarrasa, N.; Vendrell, J.; Maravall, J.; Broch, M.; Estepa, A.; Megia, A.; Soler, J.; Simon, I.; Richart, C.; Gomez, J.M. Distribution and determinants of adiponectin, resistin and ghrelin in a randomly selected healthy population. Clin. Endocrinol. 2005, 63, 329–335. [Google Scholar] [CrossRef]
  98. Rigamonti, A.E.; Pincelli, A.I.; Corra, B.; Viarengo, R.; Bonomo, S.M.; Galimberti, D.; Scacchi, M.; Scarpini, E.; Cavagnini, F.; Muller, E.E. Plasma ghrelin concentrations in elderly subjects: Comparison with anorexic and obese patients. J. Endocrinol. 2002, 175, R1–R5. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  99. Goncharova, N.D. The HPA Axis under Stress and Aging: Individual Vulnerability is Associated with Behavioral Patterns and Exposure Time. Bioessays 2020, 42, e2000007. [Google Scholar] [CrossRef]
  100. Fiske, A.; Wetherell, J.L.; Gatz, M. Depression in older adults. Annu. Rev. Clin. Psychol. 2009, 5, 363–389. [Google Scholar] [CrossRef]
  101. Otte, C.; Hart, S.; Neylan, T.C.; Marmar, C.R.; Yaffe, K.; Mohr, D.C. A meta-analysis of cortisol response to challenge in human aging: Importance of gender. Psychoneuroendocrinology 2005, 30, 80–91. [Google Scholar] [CrossRef]
  102. Van Cauter, E. Diurnal and ultradian rhythms in human endocrine function: A minireview. Horm. Res. 1990, 34, 45–53. [Google Scholar] [CrossRef]
  103. Rohleder, N.; Wolf, J.M.; Kirschbaum, C. Glucocorticoid sensitivity in humans-interindividual differences and acute stress effects. Stress 2003, 6, 207–222. [Google Scholar] [CrossRef]
  104. Mizoguchi, K.; Ikeda, R.; Shoji, H.; Tanaka, Y.; Maruyama, W.; Tabira, T. Aging attenuates glucocorticoid negative feedback in rat brain. Neuroscience 2009, 159, 259–270. [Google Scholar] [CrossRef]
  105. Murphy, E.K.; Spencer, R.L.; Sipe, K.J.; Herman, J.P. Decrements in nuclear glucocorticoid receptor (GR) protein levels and DNA binding in aged rat hippocampus. Endocrinology 2002, 143, 1362–1370. [Google Scholar] [CrossRef]
  106. Fries, E.; Dettenborn, L.; Kirschbaum, C. The cortisol awakening response (CAR): Facts and future directions. Int. J. Psychophysiol. 2009, 72, 67–73. [Google Scholar] [CrossRef]
  107. Adam, E.K.; Hawkley, L.C.; Kudielka, B.M.; Cacioppo, J.T. Day-to-day dynamics of experience--cortisol associations in a population-based sample of older adults. Proc. Natl. Acad. Sci. USA 2006, 103, 17058–17063. [Google Scholar] [CrossRef] [Green Version]
  108. Almeida, D.M.; Piazza, J.R.; Stawski, R.S. Interindividual differences and intraindividual variability in the cortisol awakening response: An examination of age and gender. Psychol. Aging 2009, 24, 819–827. [Google Scholar] [CrossRef] [Green Version]
  109. Scott, S.B.; Graham-Engeland, J.E.; Engeland, C.G.; Smyth, J.M.; Almeida, D.M.; Katz, M.J.; Lipton, R.B.; Mogle, J.A.; Munoz, E.; Ram, N.; et al. The Effects of Stress on Cognitive Aging, Physiology and Emotion (ESCAPE) Project. BMC Psychiatry 2015, 15, 146. [Google Scholar] [CrossRef] [Green Version]
  110. Hasan, K.M.; Rahman, M.S.; Arif, K.M.; Sobhani, M.E. Psychological stress and aging: Role of glucocorticoids (GCs). Age 2012, 34, 1421–1433. [Google Scholar] [CrossRef] [Green Version]
  111. Bodnoff, S.R.; Humphreys, A.G.; Lehman, J.C.; Diamond, D.M.; Rose, G.M.; Meaney, M.J. Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-aged rats. J Neurosci 1995, 15, 61–69. [Google Scholar] [CrossRef] [Green Version]
  112. Leverenz, J.B.; Wilkinson, C.W.; Wamble, M.; Corbin, S.; Grabber, J.E.; Raskind, M.A.; Peskind, E.R. Effect of chronic high-dose exogenous cortisol on hippocampal neuronal number in aged nonhuman primates. J. Neurosci. 1999, 19, 2356–2361. [Google Scholar] [CrossRef] [Green Version]
  113. Nahata, M.; Muto, S.; Nakagawa, K.; Ohnishi, S.; Sadakane, C.; Saegusa, Y.; Iizuka, S.; Hattori, T.; Asaka, M.; Takeda, H. Serotonin 2C receptor antagonism ameliorates novelty-induced hypophagia in aged mice. Psychoneuroendocrinology 2013, 38, 2051–2064. [Google Scholar] [CrossRef] [Green Version]
  114. Nakayama, S.; Nishiyama, M.; Iwasaki, Y.; Shinahara, M.; Okada, Y.; Tsuda, M.; Okazaki, M.; Tsugita, M.; Taguchi, T.; Makino, S.; et al. Corticotropin-releasing hormone (CRH) transgenic mice display hyperphagia with increased Agouti-related protein mRNA in the hypothalamic arcuate nucleus. Endocr. J. 2011, 58, 279–286. [Google Scholar] [CrossRef] [Green Version]
  115. Izzi-Engbeaya, C.; Ma, Y.; Buckley, N.W.; Ratnasabapathy, R.; Richardson, E.; Counsell, J.R.; Fernandes-Freitas, I.; Norton, M.; Farooq, G.; Mirza, Z.; et al. Effects of corticosterone within the hypothalamic arcuate nucleus on food intake and body weight in male rats. Mol. Metab. 2020, 36, 100972. [Google Scholar] [CrossRef]
  116. Tataranni, P.A.; Larson, D.E.; Snitker, S.; Young, J.B.; Flatt, J.P.; Ravussin, E. Effects of glucocorticoids on energy metabolism and food intake in humans. Am. J. Physiol. 1996, 271, E317–E325. [Google Scholar] [CrossRef]
  117. Udden, J.; Bjorntorp, P.; Arner, P.; Barkeling, B.; Meurling, L.; Rossner, S. Effects of glucocorticoids on leptin levels and eating behaviour in women. J. Intern. Med. 2003, 253, 225–231. [Google Scholar] [CrossRef]
  118. Geer, E.B.; Lalazar, Y.; Couto, L.M.; Cohen, V.; Lipton, L.R.; Shi, W.; Bagiella, E.; Conwell, I.; Bederson, J.; Kostadinov, J.; et al. A prospective study of appetite and food craving in 30 patients with Cushing’s disease. Pituitary 2016, 19, 117–126. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  119. Otto, B.; Tschop, M.; Heldwein, W.; Pfeiffer, A.F.; Diederich, S. Endogenous and exogenous glucocorticoids decrease plasma ghrelin in humans. Eur. J. Endocrinol. 2004, 151, 113–117. [Google Scholar] [CrossRef] [Green Version]
  120. Libe, R.; Morpurgo, P.S.; Cappiello, V.; Maffini, A.; Bondioni, S.; Locatelli, M.; Zavanone, M.; Beck-Peccoz, P.; Spada, A. Ghrelin and adiponectin in patients with Cushing’s disease before and after successful transsphenoidal surgery. Clin. Endocrinol. 2005, 62, 30–36. [Google Scholar] [CrossRef]
  121. Kageyama, K.; Akimoto, K.; Yamagata, S.; Sugiyama, A.; Murasawa, S.; Watanuki, Y.; Tamasawa, N.; Suda, T. Dexamethasone stimulates the expression of ghrelin and its receptor in rat hypothalamic 4B cells. Regul. Pept. 2012, 174, 12–17. [Google Scholar] [CrossRef]
  122. Yamada, C.; Sadakane, C.; Nahata, M.; Saegusa, Y.; Nakagawa, K.; Okubo, N.; Ohnishi, S.; Hattori, T.; Takeda, H. Serotonin 2C receptor contributes to gender differences in stress-induced hypophagia in aged mice. Psychoneuroendocrinology 2015, 55, 81–93. [Google Scholar] [CrossRef] [Green Version]
  123. Matsumoto, C.; Yamada, C.; Sadakane, C.; Nahata, M.; Hattori, T.; Takeda, H. Psychological stress in aged female mice causes acute hypophagia independent of central serotonin 2C receptor activation. PLoS ONE 2017, 12, e0187937. [Google Scholar] [CrossRef] [Green Version]
  124. De Mello Cruz, A.P.; Pinheiro, G.; Alves, S.H.; Ferreira, G.; Mendes, M.; Faria, L.; Macedo, C.E.; Motta, V.; Landeira-Fernandez, J. Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze. Psychopharmacology 2005, 182, 345–354. [Google Scholar] [CrossRef]
  125. Nonogaki, K. Ghrelin and feedback systems. Vitam. Horm. 2008, 77, 149–170. [Google Scholar] [CrossRef]
Figure 1. Acute stress.
Figure 1. Acute stress.
Ijms 22 11695 g001
Figure 2. Chronic stress.
Figure 2. Chronic stress.
Ijms 22 11695 g002
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Yamada, C. Involvement of Ghrelin Dynamics in Stress-Induced Eating Disorder: Effects of Sex and Aging. Int. J. Mol. Sci. 2021, 22, 11695. https://doi.org/10.3390/ijms222111695

AMA Style

Yamada C. Involvement of Ghrelin Dynamics in Stress-Induced Eating Disorder: Effects of Sex and Aging. International Journal of Molecular Sciences. 2021; 22(21):11695. https://doi.org/10.3390/ijms222111695

Chicago/Turabian Style

Yamada, Chihiro. 2021. "Involvement of Ghrelin Dynamics in Stress-Induced Eating Disorder: Effects of Sex and Aging" International Journal of Molecular Sciences 22, no. 21: 11695. https://doi.org/10.3390/ijms222111695

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop